293 related articles for article (PubMed ID: 28615470)
21. Interaction of Group B Streptococcus sialylated capsular polysaccharides with host Siglec-like molecules dampens the inflammatory response in tilapia.
Dong J; Wei Y; Sun C; Tian Y; Hu J; Shi H; Zhang D; Lu M; Ye X
Mol Immunol; 2018 Nov; 103():182-190. PubMed ID: 30291999
[TBL] [Abstract][Full Text] [Related]
22. Prevalence, serotypes and virulence genes of Streptococcus agalactiae isolated from pregnant women with 35-37 weeks of gestation.
Bobadilla FJ; Novosak MG; Cortese IJ; Delgado OD; Laczeski ME
BMC Infect Dis; 2021 Jan; 21(1):73. PubMed ID: 33446117
[TBL] [Abstract][Full Text] [Related]
23. Capsular polysaccharide of Streptococcus agalactiae is an essential virulence factor for infection in Nile tilapia (Oreochromis niloticus Linn.).
Zhang D; Ke X; Liu Z; Cao J; Su Y; Lu M; Gao F; Wang M; Yi M; Qin F
J Fish Dis; 2019 Feb; 42(2):293-302. PubMed ID: 30549284
[TBL] [Abstract][Full Text] [Related]
24. Identification of novel cps locus polymorphisms in nontypable group B Streptococcus.
Ramaswamy SV; Ferrieri P; Madoff LC; Flores AE; Kumar N; Tettelin H; Paoletti LC
J Med Microbiol; 2006 Jun; 55(Pt 6):775-783. PubMed ID: 16687599
[TBL] [Abstract][Full Text] [Related]
25. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
Kasper DL; Paoletti LC; Wessels MR; Guttormsen HK; Carey VJ; Jennings HJ; Baker CJ
J Clin Invest; 1996 Nov; 98(10):2308-14. PubMed ID: 8941648
[TBL] [Abstract][Full Text] [Related]
26. Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci).
von Hunolstein C; D'Ascenzi S; Wagner B; Jelínková J; Alfarone G; Recchia S; Wagner M; Orefici G
Infect Immun; 1993 Apr; 61(4):1272-80. PubMed ID: 8454331
[TBL] [Abstract][Full Text] [Related]
27. A novel one-step real-time multiplex PCR assay to detect Streptococcus agalactiae presence and serotypes Ia, Ib, and III.
Furfaro LL; Chang BJ; Payne MS
Diagn Microbiol Infect Dis; 2017 Sep; 89(1):7-12. PubMed ID: 28669679
[TBL] [Abstract][Full Text] [Related]
28. Genomic analysis reveals the molecular basis for capsule loss in the group B Streptococcus population.
Rosini R; Campisi E; De Chiara M; Tettelin H; Rinaudo D; Toniolo C; Metruccio M; Guidotti S; Sørensen UB; Kilian M; ; Ramirez M; Janulczyk R; Donati C; Grandi G; Margarit I
PLoS One; 2015; 10(5):e0125985. PubMed ID: 25946017
[TBL] [Abstract][Full Text] [Related]
29. Serotype IX, a Proposed New Streptococcus agalactiae Serotype.
Slotved HC; Kong F; Lambertsen L; Sauer S; Gilbert GL
J Clin Microbiol; 2007 Sep; 45(9):2929-36. PubMed ID: 17634306
[TBL] [Abstract][Full Text] [Related]
30. Use of phenotypic and molecular serotype identification methods to characterize previously nonserotypeable group B streptococci.
Kong F; Lambertsen LM; Slotved HC; Ko D; Wang H; Gilbert GL
J Clin Microbiol; 2008 Aug; 46(8):2745-50. PubMed ID: 18562579
[TBL] [Abstract][Full Text] [Related]
31. Distinct Group B
Flaherty RA; Aronoff DM; Gaddy JA; Petroff MG; Manning SD
Infect Immun; 2021 Apr; 89(5):. PubMed ID: 33558317
[TBL] [Abstract][Full Text] [Related]
32. Structure determination of Streptococcus suis serotype 2 capsular polysaccharide.
Van Calsteren MR; Gagnon F; Lacouture S; Fittipaldi N; Gottschalk M
Biochem Cell Biol; 2010 Jun; 88(3):513-25. PubMed ID: 20555393
[TBL] [Abstract][Full Text] [Related]
33. Multiple-locus variant-repeat assay (MLVA) is a useful tool for molecular epidemiologic analysis of Streptococcus agalactiae strains causing bovine mastitis.
Radtke A; Bruheim T; Afset JE; Bergh K
Vet Microbiol; 2012 Jun; 157(3-4):398-404. PubMed ID: 22266162
[TBL] [Abstract][Full Text] [Related]
34. L-Ficolin/mannose-binding lectin-associated serine protease complexes bind to group B streptococci primarily through N-acetylneuraminic acid of capsular polysaccharide and activate the complement pathway.
Aoyagi Y; Adderson EE; Rubens CE; Bohnsack JF; Min JG; Matsushita M; Fujita T; Okuwaki Y; Takahashi S
Infect Immun; 2008 Jan; 76(1):179-88. PubMed ID: 17938215
[TBL] [Abstract][Full Text] [Related]
35. Structural elucidation of type III group B Streptococcus capsular polysaccharide using molecular dynamics simulations: the role of sialic acid.
González-Outeiriño J; Kadirvelraj R; Woods RJ
Carbohydr Res; 2005 Apr; 340(5):1007-18. PubMed ID: 15780265
[TBL] [Abstract][Full Text] [Related]
36. DNA polymorphism and molecular subtyping of the capsular gene cluster of group B streptococcus.
Manning SD; Lacher DW; Davies HD; Foxman B; Whittam TS
J Clin Microbiol; 2005 Dec; 43(12):6113-6. PubMed ID: 16333106
[TBL] [Abstract][Full Text] [Related]
37. Virulence properties of type VII Streptococcus agalactiae (group B streptococci) and immunochemical analysis of capsular type polysaccharide.
VON Hunolstein C; Parisi L; Tissi L; Recchia S; Alfarone G; Nicolini L; Volpe C; Wagner B; Motlova J; Orefici G
J Med Microbiol; 1999 Nov; 48(11):983-990. PubMed ID: 10535641
[TBL] [Abstract][Full Text] [Related]
38. Chemical synthesis of the repeating unit of type Ia group B Streptococcus capsular polysaccharide.
Mondal PK; Liao G; Mondal MA; Guo Z
Org Lett; 2015 Mar; 17(5):1102-5. PubMed ID: 25674920
[TBL] [Abstract][Full Text] [Related]
39. Population structure, virulence factors and resistance determinants of invasive, non-invasive and colonizing Streptococcus agalactiae in Poland.
Sadowy E; Matynia B; Hryniewicz W
J Antimicrob Chemother; 2010 Sep; 65(9):1907-14. PubMed ID: 20584746
[TBL] [Abstract][Full Text] [Related]
40. Molecular characterization of nontypeable group B streptococcus.
Ramaswamy SV; Ferrieri P; Flores AE; Paoletti LC
J Clin Microbiol; 2006 Jul; 44(7):2398-403. PubMed ID: 16825355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
